Compare SRRK & GOLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRRK | GOLF |
|---|---|---|
| Founded | 2012 | 1910 |
| Country | United States | United States |
| Employees | 289 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 4.9B |
| IPO Year | 2018 | 2016 |
| Metric | SRRK | GOLF |
|---|---|---|
| Price | $40.03 | $93.27 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 7 |
| Target Price | $55.10 | ★ $83.67 |
| AVG Volume (30 Days) | ★ 1.1M | 364.9K |
| Earning Date | 05-28-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.10% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 3.11 |
| Revenue | N/A | ★ $1,633,721,000.00 |
| Revenue This Year | N/A | $5.01 |
| Revenue Next Year | $449.79 | $3.57 |
| P/E Ratio | ★ N/A | $29.88 |
| Revenue Growth | N/A | ★ 4.71 |
| 52 Week Low | $22.71 | $55.31 |
| 52 Week High | $49.82 | $104.81 |
| Indicator | SRRK | GOLF |
|---|---|---|
| Relative Strength Index (RSI) | 32.95 | 37.65 |
| Support Level | $29.32 | $78.60 |
| Resistance Level | $42.54 | $104.16 |
| Average True Range (ATR) | 2.24 | 3.18 |
| MACD | -0.62 | -1.15 |
| Stochastic Oscillator | 1.77 | 19.54 |
Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.
Acushnet Holdings Corp is engaged in the design, development, manufacture, and distribution of golf products. Its product category includes golf balls, golf shoes, golf clubs, wedges, putters, golf gloves, golf gear and golf wear, and others. These products are offered through different brands such as Titleist, FootJoy, Scotty Cemeron, Vokey Design, Pinnacle, KJUS, and others. The company's reportable segments are Titleist golf equipment, FootJoy golf wear, and Gofl gear. A majority of its revenue is generated by the Titleist golf equipment segment. Geographically, the company generates maximum revenue from the United States, followed by Europe, Middle East and Asia (EMEA), Japan, Korea, and the Rest of the world.